FXR knockout models exhibit hepatic steatosis, hyperlipidemia, bile acid overload, inflammation, and fibrosis,332 and these phenotypes can be ameliorated by pharmacological FXR activation.333. The gene discussed is NR1H4; the disease is Hepatic steatosis.